血红素加氧酶-1与帕金森病诊断的研究进展
Research Progress of Heme Oxygenase-1 and the Diagnosis of Parkinson’s Disease
摘要: 帕金森病(Parkinson’s disease, PD)是一种中老年人常见的神经变性疾病，至今还没有治愈方法，该疾病的诊断目前在临床上缺乏特异性指标，无法在早期作出明确诊断，因此，寻找有效的生物标志物干预疾病的进展，减缓疾病的过程引起了广泛的关注。研究发现，血红素加氧酶-1 (heme oxy-genase-1, HO-1)和PD密切相关，HO-1是一种应激蛋白，能把血红素分解成一氧化碳、铁以及胆绿素。在这篇综述中，我们谈论了HO-1及其代谢产物在PD中的作用，旨在为PD的早期诊断及预后开辟新的道路和方向。
Abstract: Parkinson’s disease (PD) is a common neurodegenerative disease in middle-aged and elderly peo-ple, and there is no cure for PD so far. The diagnosis of the disease is currently lack of specific indi-cators in clinical practice, and it is impossible to make a clear diagnosis in the early stage. Therefore, the search for effective biomarkers to intervene the progression of the disease and slow down the process of the disease has aroused wide attention. Studies have found that heme oxygenase-1 (HO-1) is closely related to PD. HO-1 is a stress protein that can break down heme into carbon monoxide, iron, and biliverdin. In this review, we talk about the role of HO-1 and its metabolites in PD, aiming to open up a new way and direction for the early diagnosis and prognosis of PD.
文章引用：刘茜, 杨晓莉. 血红素加氧酶-1与帕金森病诊断的研究进展[J]. 临床医学进展, 2023, 13(6): 10009-10015. https://doi.org/10.12677/ACM.2023.1361399

参考文献

[1] Tysnes, O.-B. and Storstein, A. (2017) Epidemiology of Parkinson’s Disease. Journal of Neural Transmission, 124, 901-905. [Google Scholar] [CrossRef] [PubMed]
[2] Li, G., Ma, J., Cui, S., He, Y., Xiao, Q., Liu, J. and Chen, S. (2019) Parkinson’s Disease in China: A Forty-Year Growing Track of Bedside Work. Translational Neuro-degeneration, 8, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[3] Li, T. and Le, W. (2020) Biomarkers for Parkinson’s Disease: How Good Are They? Neuroscience Bulletin, 36, 183-194. [Google Scholar] [CrossRef] [PubMed]
[4] Tenhunen, R., Marver, H.S. and Schmid, R. (1969) Microsomal Heme Oxygenase. Journal of Biological Chemistry, 244, 6388-6394. [Google Scholar] [CrossRef] 
[5] Wu, Y.H. and Hsieh, H.L. (2022) Roles of Heme Oxygen-ase-1 in Neuroinflammation and Brain Disorders. Antioxidants (Basel), 11, Article No. 923. [Google Scholar] [CrossRef] [PubMed]
[6] Ryter, S.W. and Choi, A.M. (2016) Targeting Heme Oxygenase-1 and Carbon Monoxide for Therapeutic Modulation of Inflammation. Translational Research, 167, 7-34. [Google Scholar] [CrossRef] [PubMed]
[7] Feng, C.W., Hung, H.C., Huang, S.Y., Chen, C.H., Chen, Y.R., Chen, C.Y., Yang, S.N., Wang, H.D., Sung, P.J., Sheu, J.H., Tsui, K.H., Chen, W.F. and Wen, Z.H. (2016) Neuropro-tective Effect of the Marine-Derived Compound 11-Dehydrosinulariolide through DJ-1-Related Pathway in in Vitro and in Vivo Models of Parkinson’s Disease. Marine Drugs, 14, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
[8] Fernandez-Fierro, A., Funes, S.C., Rios, M., Covian, C., Gonzalez, J. and Kalergis, A.M. (2020) Immune Modulation by Inhibitors of the HO System. International Journal of Molecular Sciences, 22, Article No. 294. [Google Scholar] [CrossRef] [PubMed]
[9] Cressatti, M., Song, W., Turk, A.Z., Garabed, L.R., Benchaya, J.A., Galindez, C., Liberman, A. and Schipper, H.M. (2019) Glial HMOX1 Expression Promotes Central and Peripheral Al-pha-Synuclein Dysregulation and Pathogenicity in Parkinsonian Mice. Glia, 67, 1730-1744. [Google Scholar] [CrossRef] [PubMed]
[10] Sun, W., Zheng, J., Ma, J., Wang, Z., Shi, X., Li, M., Huang, S., Hu, S., Zhao, Z. and Li, D. (2021) Increased Plasma Heme Oxygenase-1 Levels in Patients with Early-Stage Parkinson’s Dis-ease. Frontiers in Aging Neuroscience, 13, Article ID: 621508. [Google Scholar] [CrossRef] [PubMed]
[11] Schipper, H.M. and Song, W. (2015) A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders. International Journal of Molecular Sciences, 16, 5400-5419. [Google Scholar] [CrossRef] [PubMed]
[12] Fahn, S. and Cohen, G. (1992) The Oxidant Stress Hy-pothesis in Parkinson’s Disease: Evidence Supporting It. Annals of Neurology, 32, 804-812. [Google Scholar] [CrossRef] [PubMed]
[13] Gaki, G.S. and Papavassiliou, A.G. (2014) Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease. NeuroMolecular Medicine, 16, 217-230. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, Y., Gao, L., Chen, J., Li, Q., Huo, L., Wang, Y., Wang, H. and Du, J. (2021) Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease. Frontiers in Pharmacology, 12, Article ID: 757161. [Google Scholar] [CrossRef] [PubMed]
[15] Lushchak, V.I. and Storey, K.B. (2021) Oxidative Stress Concept Updated: Definitions, Classifications, and Regulatory Pathways Implicated. EXCLI Journal, 20, 956-967.
[16] Dong, H., Zhang, J., Rong, H., Zhang, X. and Dong, M. (2021) Paeoniflorin and Plycyrrhetinic Acid Synergistically Alleviate MPP(+)/MPTP-Induced Oxidative Stress through Nrf2-Dependent Glutathione Biosynthesis Mechanisms. ACS Chemi-cal Neuroscience, 12, 1100-1111. [Google Scholar] [CrossRef] [PubMed]
[17] Zawada, W.M., Banninger, G.P., Thornton, J., Marriott, B., Cantu, D., Rachubinski, A.L., Das, M., Griffin, W.S. and Jones, S.M. (2011) Genera-tion of Reactive Oxygen Species in 1-Methyl-4-Phenylpyridinium (MPP+) Treated Dopaminergic Neurons Occurs as an NADPH Oxidase-Dependent Two-Wave Cascade. Journal of Neuroinflammation, 8, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[18] Sharma, N., Khurana, N., Muthuraman, A. and Utreja, P. (2021) Pharmacological Evaluation of Vanillic Acid in Rotenone-Induced Parkinson’s Disease Rat Model. European Journal of Pharmacology, 903, Article ID: 174112. [Google Scholar] [CrossRef] [PubMed]
[19] Zou, Z.C., Fu, J.J., Dang, Y.Y., Zhang, Q., Wang, X.F., Chen, H.B., Jia, X.J., Lee, S.M. and Li, C.W. (2021) Pinocembrin-7-Methylether Protects SH-SY5Y Cells against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction through AKT and ERK Pathways. Neuro-toxicity Research, 39, 1323-1337. [Google Scholar] [CrossRef] [PubMed]
[20] Bae, J.W., Kim, M.J., Jang, C.G. and Lee, S.Y. (2010) Protec-tive Effects of Heme Oxygenase-1 against MPP(+)-Induced Cytotoxicity in PC-12 Cells. Neurological Sciences, 31, 307-313. [Google Scholar] [CrossRef] [PubMed]
[21] Jin, X., Liu, Q., Jia, L., Li, M. and Wang, X. (2015) Pinocembrin Attenuates 6-OHDA-Induced Neuronal Cell Death through Nrf2/ARE Pathway in SH-SY5Y Cells. Cellular and Molec-ular Neurobiology, 35, 323-333. [Google Scholar] [CrossRef] [PubMed]
[22] Youn, J.K., Kim, D.W., Kim, S.T., Park, S.Y., Yeo, E.J., Choi, Y.J., Lee, H.R., Kim, D.S., Cho, S.W., Han, K.H., Park, J., Eum, W.S., Hwang, H.S. and Choi, S.Y. (2014) PEP-1-HO-1 Prevents MPTP-Induced Degeneration of Dopaminergic Neurons in a Parkinson’s Disease Mouse Model. BMB Reports, 47, 569-574. [Google Scholar] [CrossRef] 
[23] Li, S.J., Ren, Y.D., Li, J., Cao, B., Ma, C., Qin, S.S. and Li, X.R. (2020) The Role of Iron in Parkinson’s Disease Monkeys Assessed by Susceptibility Weighted Imaging and Induc-tively Coupled Plasma Mass Spectrometry. Life Sciences, 240, Article ID: 117091. [Google Scholar] [CrossRef] [PubMed]
[24] Huo, T., Jia, Y., Yin, C., Luo, X., Zhao, J., Wang, Z. and Lv, P. (2019) Iron Dysregulation in Vascular Dementia: Focused on the AMPK/Autophagy Pathway. Brain Research Bulletin, 153, 305-313. [Google Scholar] [CrossRef] [PubMed]
[25] Langley, J., He, N., Huddleston, D. E., Chen, S., Yan, F., Crosson, B., Factor, S. and Hu, X. (2019) Reproducible Detection of Nigral Iron Deposition in 2 Parkinson’s Disease Cohorts. Movement Disorders, 34, 416-419. [Google Scholar] [CrossRef] [PubMed]
[26] Mahoney-Sanchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J.A. and Devedjian, J.C. (2021) Ferroptosis and Its Potential Role in the Physiopathology of Parkinson’s Disease. Progress in Neurobiology, 196, Article ID: 101890. [Google Scholar] [CrossRef] [PubMed]
[27] Masaldan, S., Bush, A.I., Devos, D., Rolland, A.S. and Moreau, C., (2019) Striking While the Iron Is Hot: Iron Metabolism and Ferroptosis in Neurodegeneration. Free Radical Biology and Medicine, 133, 221-233. [Google Scholar] [CrossRef] [PubMed]
[28] Mochizuki, H., Choong, C.J. and Baba, K. (2020) Par-kinson’s Disease and Iron. Journal of Neural Transmission (Vienna), 127, 181-187. [Google Scholar] [CrossRef] [PubMed]
[29] Choi, Y.K. and Kim, Y.-M. (2022) Beneficial and Detrimental Roles of Heme Oxygenase-1 in the Neurovascular System. International Journal of Molecular Sciences, 23, Article No. 7041. [Google Scholar] [CrossRef] [PubMed]
[30] Chen, J. (2014) Heme Oxygenase in Neuroprotection: From Mechanisms to Therapeutic Implications. Reviews in the Neurosciences, 25, 269-280. [Google Scholar] [CrossRef] [PubMed]
[31] Consoli, V., Sorrenti, V., Grosso, S. and Vanella, L. (2021) Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions. Biomolecules, 11, Article No. 589. [Google Scholar] [CrossRef] [PubMed]
[32] Figura, M. and Friedman, A. (2020) In Search of Parkinson’s Disease Biomarkers—Is the Answer in Our Mouths? A Systematic Review of the Literature on Salivary Biomarkers of Parkinson’s Disease. Neurologia i Neurochirurgia Polska, 54, 14-20. [Google Scholar] [CrossRef] 
[33] Inose, Y., Izumi, Y., Takada-Takatori, Y., Akaike, A., Koyama, Y., Kaneko, S. and Kume, T. (2020) Protective Effects of Nrf2-ARE Activator on Dopaminergic Neuronal Loss in Par-kinson Disease Model Mice: Possible Involvement of Heme Oxygenase-1. Neuroscience Letters, 736, Article ID: 135268. [Google Scholar] [CrossRef] [PubMed]
[34] Waza, A. A., Hamid, Z., Ali, S., Bhat, S.A. and Bhat, M.A. (2018) A Review on Heme Oxygenase-1 Induction: Is It a Necessary Evil. Inflammation Research, 67, 579-588. [Google Scholar] [CrossRef] [PubMed]
[35] Masaki, Y., Izumi, Y., Matsumura, A., Akaike, A. and Kume, T. (2017) Protective Effect of Nrf2-ARE Activator Isolated from Green Perilla Leaves on Dopaminergic Neuronal Loss in a Parkinson’s Disease Model. European Journal of Pharmacology, 798, 26-34. [Google Scholar] [CrossRef] [PubMed]
[36] Hung, S.Y., Liou, H.C. and Fu, W.M. (2010) The Mechanism of Heme Oxygenase-1 Action Involved in the Enhancement of Neurotrophic Factor Expression. Neuropharmacology, 58, 321-329. [Google Scholar] [CrossRef] [PubMed]
[37] Song, W., Patel, A., Qureshi, H.Y., Han, D., Schipper, H.M. and Paudel, H.K. (2009) The Parkinson Disease-Associated A30P Mutation Stabilizes Alpha-Synuclein against Proteasomal Degradation Triggered by Heme Oxygenase-1 Over-Expression in Human Neuroblastoma Cells. Journal of Neurochemistry, 110, 719-733. [Google Scholar] [CrossRef] [PubMed]
[38] Tong, H., Zhang, X., Meng, X., Lu, L., Mai, D. and Qu, S. (2018) Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxi-dant Protein in Parkinson Disease Models. Frontiers in Molecular Neuroscience, 11, Article No. 165. [Google Scholar] [CrossRef] [PubMed]

为你推荐